Flammia, R.S.; Tuderti, G.; Bologna, E.; Minore, A.; Proietti, F.; Licari, L.C.; Mastroianni, R.; Bove, A.M.; Anceschi, U.; Brassetti, A.;
et al. Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab. J. Clin. Med. 2024, 13, 5466.
https://doi.org/10.3390/jcm13185466
AMA Style
Flammia RS, Tuderti G, Bologna E, Minore A, Proietti F, Licari LC, Mastroianni R, Bove AM, Anceschi U, Brassetti A,
et al. Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab. Journal of Clinical Medicine. 2024; 13(18):5466.
https://doi.org/10.3390/jcm13185466
Chicago/Turabian Style
Flammia, Rocco Simone, Gabriele Tuderti, Eugenio Bologna, Antonio Minore, Flavia Proietti, Leslie Claire Licari, Riccardo Mastroianni, Alfredo Maria Bove, Umberto Anceschi, Aldo Brassetti,
and et al. 2024. "Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab" Journal of Clinical Medicine 13, no. 18: 5466.
https://doi.org/10.3390/jcm13185466
APA Style
Flammia, R. S., Tuderti, G., Bologna, E., Minore, A., Proietti, F., Licari, L. C., Mastroianni, R., Bove, A. M., Anceschi, U., Brassetti, A., Ferriero, M. C., Guaglianone, S., Chiacchio, G., Calabrò, F., Leonardo, C., & Simone, G.
(2024). Stratifying the Risk of Disease Progression among Surgically Treated Muscle-Invasive Bladder Cancer Eligible for Adjuvant Nivolumab. Journal of Clinical Medicine, 13(18), 5466.
https://doi.org/10.3390/jcm13185466
